Udho Thadani to Heart Failure
This is a "connection" page, showing publications Udho Thadani has written about Heart Failure.
Connection Strength
3.027
-
Trimetazidine for stable and unstable ischemic heart diseases and for heart failure: Is its routine use justified from available data? Int J Cardiol. 2020 02 01; 300:45-46.
Score: 0.519
-
Obesity, brain natriuretic peptide levels and mortality in patients hospitalized with heart failure and preserved left ventricular systolic function. Am J Med Sci. 2013 Mar; 345(3):211-7.
Score: 0.333
-
Osteoprotegerin and ST segment myocardial infarction: a novel risk marker but not for routine use at present. Cardiology. 2012; 123(2):91-3.
Score: 0.323
-
The benefit of cardiac resynchronization therapy and QRS duration: a meta-analysis. J Cardiovasc Electrophysiol. 2012 Feb; 23(2):163-8.
Score: 0.298
-
Isosorbide dinitrate/hydralazine: its role in the treatment of heart failure. Drugs Today (Barc). 2008 Dec; 44(12):925-37.
Score: 0.248
-
Effect of Obesity on Response to Spironolactone in Patients With Heart Failure With Preserved Ejection Fraction. Am J Cardiol. 2021 05 01; 146:36-47.
Score: 0.144
-
Prognostic Value of 6-Minute Walk Distance in Patients Undergoing Percutaneous Coronary Intervention: a Veterans Affairs Prospective Study. Tex Heart Inst J. 2020 02; 47(1):10-14.
Score: 0.134
-
Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure. Heart Dis. 1999 Nov-Dec; 1(5):279-88.
Score: 0.132
-
FDA Panel report: January 1998. Circulation. 1998 Jun 16; 97(23):2295-6.
Score: 0.120
-
Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure. Cardiovasc Drugs Ther. 1997 Jan; 10(6):735-42.
Score: 0.109
-
Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry. JACC Heart Fail. 2016 05; 4(5):348-56.
Score: 0.102
-
Challenges with nitrate therapy and nitrate tolerance: prevalence, prevention, and clinical relevance. Am J Cardiovasc Drugs. 2014 Aug; 14(4):287-301.
Score: 0.092
-
Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction. J Am Heart Assoc. 2013 Aug 21; 2(4):e000214.
Score: 0.086
-
Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function. Clin Cardiol. 2013 Oct; 36(10):611-20.
Score: 0.086
-
Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Circulation. 2011 Oct 25; 124(17):1811-8.
Score: 0.075
-
Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Am Heart J. 2009 Oct; 158(4 Suppl):S72-7.
Score: 0.066
-
Nitrate therapy: continuous or pulse dosing. Ration Drug Ther. 1987 Jul; 21(7):1-6.
Score: 0.056
-
Usefulness of clinical information to distinguish patients with normal from those with low ejection fractions in heart failure. Am J Cardiol. 2002 May 15; 89(10):1218-21.
Score: 0.039
-
Oral nitrates: more than symptomatic therapy in coronary artery disease? Cardiovasc Drugs Ther. 1997 May; 11 Suppl 1:213-8.
Score: 0.028
-
Nitrate tolerance. How to prevent it or minimize its effect. Postgrad Med. 1992 Apr; 91(5):307-12, 315-8.
Score: 0.020
-
Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates. Clin Pharmacokinet. 1988 Jul; 15(1):32-43.
Score: 0.015
-
Aortic valve incompetence and replacement in rheumatoid arthritis. Ann Rheum Dis. 1975 Aug; 34(4):312-20.
Score: 0.002